Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell

Clinical trial NCT02048540 · COMPLETED

Trial details

NCT number: NCT02048540
Sponsor: Chinese PLA General Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced Gastric Carcinoma

Start date: 2009-02-01
Primary completion: 2013-12-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.